Navigation Links
Isis Reports Financial Results and Highlights for Fiscal year 2007

by Isis and Isis' partners, the Company anticipates many clinical events for 2008; some are highlighted below:
* Isis' cardiovascular franchise will continue to provide clinical

evidence to support the activity and safety profiles of

second-generation antisense drugs. Isis completed two key goals

early, including the licensing of mipomersen, the lead drug in this

franchise, to Genzyme and the initiation of Phase 3 studies of

mipomersen in patients with Familial Hypercholesterolemia.

* Over the upcoming months, Isis expects to effect a seamless

transition of mipomersen development to Genzyme.

* Isis and Genzyme expect to report new safety data for


* Isis expects to initiate Phase 1 clinical studies of ISIS

353512 that targets CRP for the treatment of coronary artery


* Isis and BMS expect to advance into development a drug

targeting PCSK9 for the treatment of cardiovascular disease.

* Isis' metabolic franchise, which consists of four novel and

complementary drugs to treat type 2 diabetes, will continue to grow,

with clinical data expected from the most advanced of the four drugs,

ISIS 113715, and Isis will continue to explore the therapeutic

opportunities for antisense drugs to treat obesity.

* Isis expects to report Phase 2 study data in Type 2 diabetics

treated with ISIS 113715 and sulfonylureas.

* Isis expects to complete the Phase 1 study of ISIS 325568, an

antisense drug licensed to OMI that targets GCGR to treat

diabetes. Isis expects OMI will choose to initiate Phase 2

studies of ISIS 325568 in patients with type 2 diabetes.

* Isis' partners developing antisense drugs

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
2. Haemacure Reports Third Quarter 2007 Results
3. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
4. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
5. MDS Reports Third Quarter 2007 Results
6. Allied Healthcare Reports Strong Fourth Quarter, Flat Net Income for Fiscal 2007 vs. 2006
7. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
8. NMHC Reports Fourth Quarter and Fiscal Year 2007 Financial Results
9. Blue Cross and Blue Shield of Florida Reports Eighteenth Consecutive Year of Positive Performance
10. ReBuilder Medical Technologies, Inc. Reports International Sales Expansion
11. AdCare Health Systems, Inc. Reports Discontinuation of Definitive Merger Agreement with Family Home Health Services, Inc.
Post Your Comments:
(Date:12/17/2014)... This prestigious award is given annually ... outstanding and innovative contributions to the physical therapy ... practice physical therapy by the Private Practice Section ... behalf of Performance Physical Therapy, Michelle Collie PT, ... accepted the award at the Private Practice, APTA ...
(Date:12/17/2014)... 17, 2014 No matter how far ... to eradicate the head louse parasite—a common childhood malady ... Each year between six and twelve million individuals will ... lice removal treatment company comes to the rescue, providing ... friendly. With its track record of customer service, and ...
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, ... one worrisome phenomenon is when an illness that originated in ... as zoonosis -- is not uncommon and keeps researchers on ... disease might make inroads into the human population. A ... the culprits in this case were guinea pigs. More specifically, ...
(Date:12/17/2014)... HealthDay Reporter TUESDAY, Dec. 16, ... approaching, a new study reveals that states that routinely perform ... drivers on their roads. The finding suggests that states ... to deter inebriated revelers from getting behind the wheel in ... passed regarding drinking and driving," said study lead author James ...
(Date:12/15/2014)... Cancer researchers have just published an ... of deadly malignant pleural mesothelioma. Surviving Mesothelioma has just ... Click here to read it now. , ... Center, and New York’s Langone Medical Center performed complete ... in an effort to pinpoint the genes that ...
Breaking Medicine News(10 mins):Health News:Performance Physical Therapy Awarded with Jayne L. Snyder Private Practice of the Year 2014 2Health News:Lice Troopers Announces New Lice Treatment Clinic in Coral Gables to Service Key Biscayne, Coconut Grove, Kendall, Brickell & South Miami 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 2Health News:Guinea Pigs Can Be Source of Serious Strep Infection 3Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 2Health News:Enforcement of Drunk Driving Laws Makes Roads Safer, Study Finds 3Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2
... Repetitive magnetic stimulation of the brain (rTMS) is considered as ... is found to improve patient movement on the side of ... research it is found that the unaffected side of the ... signals to the affected side that actually impair the patient's ...
... Researchers have concluded that earlier a deaf child receives cochlear implants ... and use of words//. ,When a 3? year-old child, ... in nine months earlier, the right time to make use of ... who had a cochlear implant 31 months earlier made more sophisticated ...
... its policy of short-term solutions a trade union has launched ... that fewer than one in five graduating student nurses would ... forced to recruit overseas to meet workforce targets because of ... guaranteed students a job once they qualify after three years ...
... who are regular with their intake of medications, even if ... those //who don’t adhere to any pattern, according to Canadian ... researchers observe its effects on groups of participants, who are ... into the fray if it scores better in treatment during ...
... used against two of the world's most lethal viruses namely ... that it would be possible to create cheap vaccines that ... is a very large need but no funds available to ... that Rurik Salyaev, of the Siberian Institute of Plant Physiology ...
... health bosses who have told staff to leave corpses on ... hospital bed for four days//, lashed out at them saying ... cash-strapped bosses are not paying for enough night porters to ... ,While an NHS chief confirmed that a body ...
Cached Medicine News:Health News:Earlier the Cochlear Implants Used Better the Speech 2Health News:Earlier the Cochlear Implants Used Better the Speech 3Health News:Nurses Face Unemployment 2Health News:Dead Body on Hospital Bed for Four Days 2
(Date:12/15/2014)... , Dec. 15, 2014  Colorado and ... have legalized adult use of cannabis. Oregon ... D.C. ended prohibition during the November 2014 elections. ... Photo - The benefits ... noted and obvious benefits like the increased tax revenue for ...
(Date:12/15/2014)... 2014   DaVita HealthCare Partners Inc.  (NYSE: ... largest and most innovative health care communities, today ... DaVita Clinical Research  (DCR) and  HealthCare Partners Clinical Research ... extensive clinical research and data analytics services, specifically ... end-stage renal disease (ESRD), as well as primary ...
(Date:12/13/2014)... 11, 2014 Research and Markets ... the "Drug Injection Devices to 2020" ... As new drugs ... list of health conditions, drug developers have increasingly ... administration process and increase the efficiency and reliability ...
Breaking Medicine Estimates 200,000 New Jobs in the Cannabis Industry by 2015 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 2DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 3DaVita Clinical Research and HealthCare Partners Clinical Research to Merge and Expand Clinical Trials and Data Analytics Capabilities 4Drug Injection Devices to 2020 2Drug Injection Devices to 2020 3Drug Injection Devices to 2020 4
... ( US HIFU ), a world leader in minimally invasive ... ) technologies and manufacturer of the Sonablate® 500 medical device ... available to prostate cancer patients for the first ... Curitiba, capital city of the state of Parana in southern ...
... Medical, Inc. ("Kips Bay"), a development stage medical device ... vein support technology, or eSVS MESH, for use in ... it has closed its previously announced offering of 2,062,500 ... $8.00 per share.   Kips Bay ...
Cached Medicine Technology:Sonablate® HIFU for Prostate Cancer in New Locations Outside the U.S. 2Sonablate® HIFU for Prostate Cancer in New Locations Outside the U.S. 3Sonablate® HIFU for Prostate Cancer in New Locations Outside the U.S. 4Kips Bay Medical Announces Closing of its $16.5 Million Initial Public Offering of Common Stock 2
This cannula is flanged with radiopaque tip with 2 side holes....
This cannula features a PVC body, auto inflatable smooth cuff, pressure monitoring line with integral stopcock....
The KAVD Venous Cannula is the first of its kind. It is a combination of cannulae/venous line designed to "bridge the gap between the patient and the Medtronic Resting Heart System circuit....
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures...
Medicine Products: